Edition:
United States

Abiomed Inc (ABMD.OQ)

ABMD.OQ on NASDAQ Stock Exchange Global Select Market

140.47USD
27 Jun 2017
Change (% chg)

-- (--)
Prev Close
$140.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
114,607
52-wk High
$147.21
52-wk Low
$95.16

Select another date:

Thu, May 4 2017

BRIEF-Abiomed says enrolled first patient in FDA approved prospective feasibility study

* Abiomed - enrollment of first patient in fda approved prospective feasibility study, STEMI door to unloading with Impella CP system in acute myocardial infarction

BRIEF-Abiomed Q4 gaap earnings per share $0.33

* Abiomed announces Q4 fy 2017 revenue of $124.7 million, up 33% over prior year and total year revenue of $445.3 million, up 35% over prior year

BRIEF-Abiomed announces Q4 revenue of $124.7 million, up 33 pct

* Abiomed announces q4 fy 2017 revenue of $124.7 million, up 33% over prior year and total year revenue of $445.3 million, up 35% over prior year

BRIEF-Abiomed Q3 GAAP earnings per share $0.34

* Abiomed announces Q3 FY 2017 revenue of $114.7 million, up 34% over prior year

BRIEF-Abiomed Q3 earnings per share $0.34

* Says increasing lower end of its fiscal year 2017 revenue guidance with new range of $440 million to $445 million

BRIEF-Abiomed announces preliminary q3 preliminary revenue

* Abiomed announces preliminary q3 fy 2017 revenue of $114.7 million, up 34% over prior year

Select another date:

More From Around the Web